Compass Therapeutics Gears Up for Major Healthcare Conference
BOSTON — Compass Therapeutics, Inc. (Nasdaq: CMPX), known for its innovative approach toward developing antibody-based therapeutics for oncology, is preparing to present at the prestigious J.P. Morgan 2026 Healthcare Conference. This event, scheduled for January 14, 2026, will serve as a pivotal moment for the company as it seeks to engage with potential investors and showcase its advancements in clinical-stage therapies.
Details of the Presentation
The presentation at the J.P. Morgan Healthcare Conference is set to begin at 7:30 AM PT. Attendees will have the opportunity to gain insights into Compass Therapeutics' ongoing research and development initiatives. This presentation is anticipated to highlight the latest advancements in therapeutic strategies and results related to their unique product candidates.
Accessing the Event
For those unable to attend the live presentation, a recorded version will be made available afterwards. Investors can find this on Compass’ events page, ensuring that they remain updated on the company's progress even if they miss the live session.
Investor Engagement Opportunities
On January 14, 2026, Compass Therapeutics invites interested investors to arrange one-on-one meetings with key company representatives, facilitating a more personalized discussion regarding their innovative pipeline and future plans. This meeting offers a unique platform for investors to dive deeper into Compass’ development projects and strategic vision.
Participation in LifeSci Partners Corporate Access Event
In addition to showcasing at the J.P. Morgan conference, Compass Therapeutics is also scheduled to participate in the LifeSci Partners Corporate Access Event on January 12 and 13, 2026. This event, taking place in San Francisco, CA, represents another strategic opportunity for Compass Therapeutics to connect with investors and stakeholders, laying the foundation for fruitful relationships moving forward.
About Compass Therapeutics
Founded in 2014, Compass Therapeutics is driven by the quest to create effective therapeutic solutions to combat human diseases, particularly in the oncology space. The company’s core focus revolves around understanding the complex interactions between angiogenesis, the immune system, and tumor growth, paving the way for the development of novel treatments. Their robust pipeline features multiple promising product candidates designed to engage crucial biological pathways essential for an effective anti-tumor response, including innovative methods to counteract tumoral defenses that hinder immune surveillance.
The Company’s Vision
Compass Therapeutics envisions moving its product candidates through rigorous clinical trials, either as standalone therapies or in synergy with other proprietary antibodies. This dual-approach empowers the company to leverage both established therapies and emerging treatment paradigms to enhance patient outcomes.
Leadership and Expertise
With a team comprised of leading experts in biotechnology, Compass Therapeutics is harnessing their collective expertise to propel the company’s mission. Their collaborative environment is optimized for developing groundbreaking therapeutic solutions aimed at challenging diseases thought to be difficult to treat.
Contact Information
Those interested in learning more about Compass Therapeutics or scheduling meetings during the upcoming conferences can reach out via the following channels: for investor inquiries, please contact ir@compasstherapeutics.com, and for media inquiries, reach out to Anna Gifford, Chief of Staff, at media@compasstherapeutics.com or call 617-500-8099.
Frequently Asked Questions
What is Compass Therapeutics?
Compass Therapeutics is a biopharmaceutical company focusing on oncology through the development of antibody-based therapeutics.
When will Compass present at the J.P. Morgan Healthcare Conference?
Compass Therapeutics will present on January 14, 2026, at 7:30 AM PT.
How can investors participate in meetings with Compass?
Investors can arrange one-on-one meetings by contacting their J.P. Morgan representative on January 14, 2026.
What are the key areas of focus for Compass Therapeutics?
The company is focused on the relationship between angiogenesis, immune response, and tumor growth, aiming to create effective cancer treatments.
Where can I find more information about Compass Therapeutics?
For more details, visit the official Compass Therapeutics website at https://www.compasstherapeutics.com.
